ImmunOs Therapeutics AG Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023. Excellent presentation team! Osiris Marroquin Belaunzaran Anahita Rafiei, PhD Discover more here_ https://lnkd.in/eCBzQtiC #immunotherapy #cancer #oncology #esmo #bispecifics #cancertherapy #antitumor #HLA #multitarget #multimodal #immunooncology
ImmunOs Therapeutics AG’s Post
More Relevant Posts
-
Don’t miss Aqtual, Inc.’s poster presentation, “Detection of non-small cell lung and bladder cancer signatures in peripheral blood using a novel active chromatin capture assay,” taking place today between 9:00 AM - 12:30 PM. Session Category: Clinical Research Session Title: Circulating Nucleic Acids 4 Location: Poster Section 40; Poster Board 15 Published Abstract Number: 5028 #cfDNA #AACR24 #lungcancer #bladdercancer #oncology #PrecisionMedicine
-
-
Focused to identify, develop and launch innovative solutions for severe medical conditions. ***posts, views and opinions are personal and are not related to my past and current employers, partners and clients***
New Research: α-synuclein, together with DJ-1, may play a role in melanoma progression and chemosensitivity, constituting novel targets for therapeutic intervention, and possible biomarkers for melanoma. https://lnkd.in/diUZ7KDS #cancer #cancerresearch #synuclein #melanoma
-
-
Resurgence of Smart 🎯 Chemo is on the rise 🚀 , led by Antibody Drug Conjugates that precisely deliver cytotoxic drugs 💊 to tumor cells whilst sparing normal cells the toxicity ☢ of chemotherapeutic agents. Here is a good introduction to ADCs. https://lnkd.in/e69-_g_g #chemotherapy #adc #cancer #cancerresearch #cancertreatment #oncology #oncologyresearch #precisiononcology #precisionmedicine
-
🔬 Insights from ASCO 2024! Prof els Van Nieuwenhuysen from University Hospitals Leuven presents the ongoing trial on ubamatamab for recurrent ovarian and endometrial cancer. The study explores dose escalation, early efficacy signals, and strategies to mitigate cytokine release syndrome. Learn more about the potential of this bispecific antibody therapy. Discover these updates.👇 For all ASCO 2024 videos, find the link in the comments! #MediMix #ASCO2024 #GynaecologicalCancer #OncologyInnovation #OvarianCancer #EndometrialCancer
-
Bioinformatics • Liquid Biopsy • Cancer Biomarkers • Computational Cancer Genomics • Opinions Are My Own
Selected targetable biomarkers in solid tumours (from https://lnkd.in/g8pYkZwK) #biomarkers #cancer #oncology #cancerresearch #oncologyresearch #precisionmedicine #preventivemedicine
-
-
Explore our new findings. Pancreatic cancer organoids innovate drug screening for tailored treatments. See more in details: https://lnkd.in/d7NpTJD7 #CancerTreatmentRevolution #DrugScreening #OrganoidInnovation #PancreaticCancerResearch #PersonalizedTherapies #reseapro #reseaprojournals #CancerResearch #cancer #trending #cancerjournal #medx #newjournals #newpost
-
-
Early #diagnostic of #pancreaticcancer : 2 important announces this week from Immunovia AB and City of Hope Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study https://lnkd.in/gm_ncUNy An Exosome-based Liquid Biopsy Shows Promise for Early Detection of Pancreatic Cancer https://lnkd.in/dj5CZUB6 However, predictive diagnostics developed by ACOBIOM are needed to target 1st line therapies (#gemcitabine, #FOLFIRINOX). For more information: https://lnkd.in/gFGE6-AW
-
-
Epigenetic editing tools are making therapeutic T cells to better kill cancer.
“We are proud to partner with Kite Pharma to extend the potential application of Epic’s platform for cancer treatment. Epic’s approach is promising for in vivo medicines and may enable next-generation cell therapies to reach a wide range of patient populations.” Amber Salzman, Ph.D., CEO, Epic Bio. Read more here: https://lnkd.in/gCb9-6jJ #epigenetics #CellTherapy #Cancer
-
Watch an #oncotargetshort #video about this #research paper: "Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy." https://lnkd.in/gKx6Z3R3 #cancer #trendingwithimpact #pancreaticcancer #research #oncologyresearch #openaccess #peerreviewed #publishing #meded
-
Duke-NUS researchers have made a significant breakthrough in understanding why certain pancreatic and colorectal cancers do not respond to Wnt inhibitors, a promising type of cancer medication currently in development. Their findings, published in Science Advances, not only reveal a potential new target for cancer treatment, but also introduce a potential screening method for identifying patients who will not benefit from this medication once it is made available. Read more about it from the link in the comments. 📸: istock #DukeNUSResearch #DukeNUS #pancreaticcancer #colorectalcancer #cancertherapy #medication
-
...
7mo¡Felicidades!